About Enveda
Enveda is a company based in Boulder (United States) founded in 2019. Enveda has raised $504.46 million across 11 funding rounds from investors including Microsoft, SVB and Sanofi. The company has 103 employees as of March 28, 2024. Enveda offers products and services including Enveda Platform. Enveda operates in a competitive market with competitors including Aqemia, NTxBio, Nimble Therapeutics, Applied BioMath and IMIDomics, among others.
- Headquarter Boulder, United States
- Employees 103 as on 28 Mar, 2024
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Enveda Therapeutics India Private Limited
- Date of Incorporation 08 Aug, 2019
- Jurisdiction Visakhapatnam, Andhra Pradesh, India
-
Annual Revenue
$3.94 M (USD)117.1as on Mar 31, 2023
-
Net Profit
$683.67 K (USD)90.72as on Mar 31, 2023
-
EBITDA
$1.31 M (USD)142.74as on Mar 31, 2023
-
Total Equity Funding
$504.46 M (USD)
in 11 rounds
-
Latest Funding Round
$150 M (USD), Series D
Sep 04, 2025
-
Investors
Microsoft
& 31 more
-
Employee Count
103
as on Mar 28, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Enveda
Enveda offers a comprehensive portfolio of products and services, including Enveda Platform.
Platform analyzes natural molecules for faster medicine development
Funding Insights of Enveda
Enveda has successfully raised a total of $504.46M across 11 strategic funding rounds. The most recent funding activity was a Series D round of $150 million completed in September 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Enveda
Enveda has secured backing from 32 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Microsoft, SVB and Sanofi.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are directed toward multiple sectors by Kinnevik.
|
Locked | Locked | Locked | |
|
Provides venture capital for technology startups and enterprise innovations worldwide.
|
Locked | Locked | Locked | |
|
Seed and early-stage technology companies are funded by Lux Capital.
|
Locked | Locked | Locked |
Investor details for Enveda
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Enveda
Investment portfolio details for Enveda
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Enveda
Detailed financials for Enveda
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Enveda Comparisons
Peer comparison for Enveda
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Enveda
Enveda operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aqemia, NTxBio, Nimble Therapeutics, Applied BioMath and IMIDomics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutic molecules are discovered through AI and quantum physics integration.
|
|
| Locked | Locked | Locked |
Provider of bio informatics platform to develops biologics and therapeutics
|
|
| Locked | Locked | Locked |
Combinatorial chemistry services for peptide-based drug discovery are provided.
|
|
| Locked | Locked | Locked |
Systems biology and pharmacology modeling services to aid drug discovery and development
|
|
| Locked | Locked | Locked |
Precision medicines for immune-mediated inflammatory diseases are developed.
|
Detailed competitors of Enveda
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Enveda
Complete news archive for Enveda
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Enveda
Enveda was founded in 2019.
Enveda is headquartered in Boulder, United States. It is registered at Boulder, Colorado, United States.
Enveda is a funded company, having raised a total of $504.46M across 11 funding rounds to date.
As of Mar 28, 2024, the latest employee count at Enveda is 103.
Annual revenue of Enveda is $3.94M as on Mar 31, 2023.
Enveda was founded in 2019 in Boulder, United States, as a biotechnology company focused on drug discovery. Advanced computational methods and metabolomics are employed by the platform to analyze natural chemical compounds and identify potential treatments for diseases. Drug development processes are accelerated through the integration of nature-derived chemical insights, supporting research in the pharmaceutical sector.
Enveda offers Enveda Platform.
Enveda has 32 investors. Key investors include Microsoft, SVB, Sanofi, Baillie Gifford, and Allen & Company.